Nanomedicine’s novel approach to diagnosis at the molecular level offers the prospect of detecting and locating diseases such as arteriosclerosis at an early stage, already applied for disease costly hospitalisation, improve recovery and enable some patients with previously untreatable or incurable illness to return to productive work, with a good quality of life.
[...]